BNET Industries
Bayer AG is in the Manufacturing Industry
Latest News and Analysis
Bayer and Barr Agree Oral Contraceptive Deal
By James Regan FRANKFURT (Reuters) - Germany's Bayer AG BAYG agreed to supply a generic version of its Yasmin oral contraceptive for Barr Pharmaceuticals Inc BRL to market in the United States in return for a fixed portion of sales. Bayer said it...
Four Higher-Price Champions
The best way to win a pricing war is to avoid the fight entirely. These products do battle in tough markets, but they generate profits without competing on the basis of price. The Champion: Apple...
Bayer Business Services: Shared Portal Concept
Bayer Business Services BBS is the Bayer's Group competence center for IT-based business, administrative and scientific services. The challenge was to simplify the authentication and authorization processes of 'Electronic workplaces' in the Bayer Group worldwide. BBS created a modular web portal architecture with a personalized look & feel. As a...
Bayer Business Services Speeds Business Intelligence With SAP and IBM
Bayer MaterialScience BMS, one of the three Bayer AG subgroups, was seeking approaches to cope both now and in the future with the rapid growth in data volume generated within its SAP Netweaver Business Intelligence BI data warehouse system. If it could collate data and produce meaningful information more rapidly,...
Low Cost Radar on Scrubber Vessel Level at Bayer
The article is case study on VEGAPULS radar. An application recently successfully solved includes a vent scrubber vessel on an agrochemical intermediate plant where caustic spray is used to clean waste vapors from the process. This process causes a turbulent liquid surface with heavy vapors. Problems were encountered with crystallization...
Bayer Pharmaceuticals and Chemicals Industry: Developing Tomorrow's Leaders With an Initiative That Understands Change
This major chemical, crop, science and pharmaceutical company had enjoyed success with a decentralized "Command and Control" approach to leadership. As it moved into a complex organizational change process aimed at operating more flexibly and competitively in its markets, an elemental part of the challenge revolved around meeting the developmental...
Additional Resources
Summary Notice of Settlement of Bayer AG Securities Litigation
WHITE PLAINS, N.Y., July 9 /PRNewswire/ -- The following release was issued today by Thomas M. Skelton and Richard W. Cohen of Lowey Dannenberg Cohen & Hart, P.C.: UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK In re BAYER AG SECURITIES LITIGATION File...
FDA Approves EOVIST® to Detect and Characterize Focal Liver Lesions
First Organ-specific MRI Contrast Agent Approved in the United States in More Than a Decade WAYNE, N.J., July 8 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc., a leader in diagnostic imaging, announced today that the U.S. Food and Drug Administration FDA has approved EOVISTR Gadoxetate Disodium Injection, a...
Avaya Appoints Michael Bayer to Lead EMEA Field Operations Organisation
Avaya, a leadingglobal provider of business communications applications, systems andservices, today announced it has appointed Michael Bayer as president ofAvaya's field operations in Europe, Middle East and Africa EMEA. In his new role, Bayer will lead the region's sales and operations and alsowill work with customers to deliver Avaya's advanced...
NOXXON Pharma Announces Appointment of Lawrence E. Posner to Its Board of Directors
BERLIN -- NOXXON Pharma AG NOXXON, developer of mirror image oligonucleotide therapeutics termed Spiegelmers([R]), announced today the appointment of Lawrence E. Posner, MD, to its Board of Directors. Dr. Posner brings to NOXXON over 25 years of experience in pharmaceutical research and development. He has held executive R...
OptumHealth Introduces New "Brain Health" Capabilities
Exclusive Agreement with Brain Resource Allows for Improved Speed and Accuracy in Diagnosis and Treatment, Improving Outcomes While Reducing Costs GOLDEN VALLEY, Minn. -- OptumHealth announced today that it has signed a three-year agreement to exclusively license Brain Resource Ltd.'s behavioral health technology in the U.S. managed care...
Bayer HealthCare and Maxygen Announce Hematology Agreement
-Portfolio of Hemophilia Drug Candidates Includes Novel Recombinant Factor VIIa- -$120 Million Transaction Includes License to Maxygen's Novel Biotechnology Research Platform- -Phase 1 Clinical Testing Expected to Commence in Third Quarter- LEVERKUSEN, Germany & REDWOOD CITY, Calif. -- Bayer HealthCare is expanding its commitment...
Journal of Clinical Oncology Publishes Leukine® Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma
- Phase II Trial Shows Increase in Mature Dendritic Cells - WAYNE, N.J., June 30 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals today confirmed that results of a Phase II trial were published in the July 1 edition of the Journal of Clinical Oncology. The study showed that...
Bayer Uses InSync Software to Develop and Deploy RFID and Sensor Applications
Solutions Focus on Warehouse and Logistics Automation, Improving Operational Efficiency and Reducing Risk SAN JOSE, Calif., June 30 /PRNewswire/ -- Bayer Material Science, one of the world's largest producers of polymers and high-performance plastics, announced it is deploying a series of RFID and sensor-enabled warehousing and logistics...
SEX DOCTOR: KNOW YOUR HORMONES
MORE than 3.5 million women in the UK take the combined oral contraceptive every day. But how much do you know about the pill you're taking? Research by Bayer Schering Pharma compared how much women know about their dietary intake with how much they know about their pill - and...
Football: BALLACK IS OUR MARADONA
MICHAEL Ballack is on the verge of finally being accepted as a German hero. For all his ability, the Chelsea star has never occupied the same place in the hearts of the German public as icons like Franz Beckenbauer, Jurgen Klinsmann and Boris Becker. ...
Ballack gets yet another shot at final redemption
It is just as well that Germany's captain Michael Ballack is gracious in defeat. He has endured plenty of practice on the biggest of occasions. The threat hanging over him for an unexpectedly long time here last night was of another sickening fall at the last hurdle but one, to...
Biomedical Materials May 2008 Issue Including Research Alerts, Industry News and Regulatory Affairs
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/bc575f/biomedical_materia) has announced the addition of the "Biomedical Materials - May 2008 Issue" report to their offering. Materials: Manhattan Scientifics flags intent to buy Metallicum Products: * Valve offers improved solution for regaining of speech after...
BioPharm America™ Features Top Industry Decision-Makers in Life Science Partnering
CARLSBAD, Calif. and ATLANTA -- Navigating a shifting landscape of bio-pharma deal making will be the focus for discussions among licensing and business development executives from Bayer Schering, Novo Nordisk, Novartis, Pfizer, Johnson & Johnson and Shire Pharmaceuticals at BioPharm America[TM] in Atlanta, September 9-10, 2008. The backdrop...
Barr and Bayer Sign Supply and Licensing Agreements for Launch of Generic Yasmin® and Yaz® Oral Contraceptives
- Barr Plans to Launch Generic YasminR on or before July 1, 2008 - Barr Plans to Launch Generic YazR on or before July 1, 2011 - Bayer to Continue Appeal of YasminR District Court Decision MONTVALE, N.J., June 24 /PRNewswire-FirstCall/ -- Barr...
- Next »
- page 1 of 453
- « Previous
